Related Experiment Video
Updated: Aug 8, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
Published on: June 4, 2012
Penicillin sensitive nutritionally variant streptococcal endocarditis: relapse after penicillin therapy
Abstract:
Studies to date have indicated that nutritionally-variant streptococci (NVS) causing bacterial endocarditis are frequently inhibited but not killed by low concentrations of penicillin. We report a patient with endocarditis due to a NVS strain which was killed in vitro by penicillin at a concentration of 0.09 microgram/ml. Despite therapy with intravenous penicillin for four weeks, the infection relapsed and was then cured by combined penicillin-gentamicin in therapy. In vitro studies demonstrated a synergistic effect of these two antibiotics. This experience suggests that combination therapy with penicillin and an aminoglycoside may be required for cure of all cases of nutritionally-variant streptococcal endocarditis regardless of in vitro susceptibility to penicillin.
Insights
Nutritionally-variant streptococci (NVS) endocarditis may require combination antibiotic therapy. Penicillin alone may not suffice, even if the bacteria appear susceptible in vitro, suggesting a need for penicillin-aminoglycoside treatment.
Area of Science:
- Infectious Diseases
- Cardiology
- Microbiology
Background:
- Nutritionally-variant streptococci (NVS) are a cause of bacterial endocarditis.
- NVS are often inhibited, not killed, by standard penicillin concentrations.
- Effective treatment strategies for NVS endocarditis require further investigation.
Observation:
- A patient presented with endocarditis caused by an NVS strain.
- This specific NVS strain was killed in vitro by a low penicillin concentration (0.09 µg/ml).
- Despite four weeks of intravenous penicillin therapy, the patient experienced a relapse.
Findings:
- The relapsed infection was successfully treated with a combination of penicillin and gentamicin.
- In vitro studies confirmed a synergistic effect between penicillin and gentamicin against the NVS strain.
- This suggests that penicillin susceptibility in vitro does not guarantee cure for NVS endocarditis.
Implications:
- Combination therapy with penicillin and an aminoglycoside may be essential for treating all NVS endocarditis cases.
- Current in vitro susceptibility testing may not fully predict treatment outcomes for NVS endocarditis.
- This finding could alter clinical guidelines for managing NVS endocarditis.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Myocarditis III: Medical Management
Rheumatic Heart Disease III: Medical Management
